SCHEMBL28046385

SCHEMBL28046385

O=CC(=O)c1c(Cl)c(NCc2ccccc2)cn1Cc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 3/20 0.40
KAT2B Q92831 1/20 0.40
BRD9 Q9H8M2 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 2/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
HSD17B10 Q99714 1/20 0.38
BRD2 P25440 1/20 0.38
BRD3 Q15059 1/20 0.38
BRDT Q58F21 1/20 0.38
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
ADRA1D P25100 1/20 0.37
CISD1 Q9NZ45 1/20 0.37
KDM6B O15054 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27934873 0.71 HPGD (0.46) BRD4HDAC1HDAC8HDAC6ALDH1A1
SCHEMBL28080836 0.70 F2RL3 (0.39) BRD4ALDH1A1LMNABRD2BRD3
SCHEMBL28905120 0.69 GAA (0.41) ALDH1A1LMNAMEN1KMT2AEGLN1
SCHEMBL27704041 0.67 BRD4 (0.39) BRD4BRD2BRD3BRDT
SCHEMBL28080903 0.67 ALDH1A1 (0.43) ALDH1A1KDM4ELMNAPOLBMEN1
SCHEMBL27721655 0.66 ADRA1D (0.41) HDAC1HDAC8HDAC6ALDH1A1POLB
SCHEMBL28829351 0.65 FLT1 (0.60) ALDH1A1KDM4EMAPT
SCHEMBL27770330 0.65 CHRM1 (0.43) HDAC8HDAC6LMNA
SCHEMBL10349900 0.64 CNR2 (0.52) BRD4HDAC8HDAC6ALDH1A1KDM4E
SCHEMBL28716413 0.64 ACHE (0.37) BRD4BRD2BRD3BRDTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105209457-A Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy ABBVIE DEUTSCHLAND 2015-12-30 CN disclosed